LH · News · 20260809N
Guidance / Outlook
LABCORP HOLDINGS INC. · 2026-08-09 · Importance 57 · Surprise 60 · In source text
Labcorp raised its full-year 2026 revenue and adjusted EPS guidance after reporting second-quarter 2026 results. Management attributed the increase to strength in specialty testing, Central Laboratories, and strategic initiatives across Diagnostics and Biopharma Laboratory Services. A separate report said the company increased quarterly sales and raised its full-year 2026 revenue-growth guidance, with projections calling for $16.6 billion of revenue by 2029.
Key facts
- Labcorp's financial projections forecast $16.6 billion in revenue by 2029. source
- The company raised its full-year revenue and adjusted EPS guidance. source
- Labcorp reported increased quarterly sales and an uplift in its full-year 2026 revenue growth guidance. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Labcorp's financial projections forecast $16.6 billion in revenue by 2029. |
| net_income | positive | probable | — | The company raised its full-year revenue and adjusted EPS guidance. |
| revenue | positive | realized | — | Labcorp reported increased quarterly sales and an uplift in its full-year 2026 revenue growth guidance. |
| revenue | positive | probable | — | Labcorp reported increased quarterly sales and an uplift in its full-year 2026 revenue growth guidance. |